8-K
filed August 18, 2023, 7:59 PM ET
ticker AXGN
CIK 0000805928
other material
confidence high
sentiment negative
materiality 0.15
Axogen shareholders reject incentive plan share increase at 2023 annual meeting
Axogen, Inc.
- Proposal to increase LTIP shares from 8M to 10.5M failed with 11.3M for vs 18.6M against (excluding broker non-votes).
- ESPP share increase (600K to 1.2M) approved with 27.4M for, 2.6M against.
- Bylaws amendment to set board size range of 7-11 members approved with 34.1M for, 0.9M against.
- All nine director nominees elected; highest withheld was Guido Neels with 7.2M withheld.
- Say-on-pay passed with 28.6M for, 1.4M against; auditor ratification approved with 34.9M for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Axogen, Inc. shareholders approved Election of nine directors to serve for a one-year term until the 2024 annual meeting of shareholders at the 2023-08-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-08-15
Exact text from the filing
Nine directors were elected to the Company’s Board of Directors (the "Board") to serve for a one-year term until the 2023 annual meeting of shareholders. The results of the election were as follows: Name For Withheld Broker Non-Votes Karen Zaderej 29,010,146 1,124,288 4,943,673 Amy Wendell 29,004,864 1,129,570 4,943,673 William Burke 28,413,152 1,721,282 4,943,673 Gregory Freitag 29,040,709 1,093,725 4,943,673 John H. Johnson 23,637,550 6,496,884 4,943,673 Alan Levine 29,215,878 918,556 4,943,673 Guido Neels 22,945,316 7,189,118 4,943,673 Paul Thomas 28,834,881 1,299,553 4,943,673 Joseph Tyndall, MD MPH, FACEP 29,410,761 723,673 4,943,673
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Axogen, Inc. shareholders approved Advisory (non-binding) vote on executive compensation of named executive officers at the 2023-08-15 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-08-15
Exact text from the filing
For Against Abstentions Broker Non-Votes 28,598,027 1,372,361 164,046 4,943,673
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Axogen, Inc. shareholders approved Ratification of Appointment of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2023 at the 2023-08-15 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-08-15
Exact text from the filing
For Against Abstentions Broker Non-Votes 34,923,002 146,443 8,662 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Axogen, Inc. shareholders approved Amendment and restatement of Axogen, Inc. 2017 Employee Stock Purchase Plan to increase shares from 600,000 to 1,200,000 at the 2023-08-15 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-08-15
Exact text from the filing
For Against Abstentions Broker Non-Votes 27,438,032 2,597,564 98,838 4,943,673
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Axogen, Inc. shareholders approved Amendment to Bylaws to set Board size range of 7 to 11 members and allow Board to set specific number within that range at the 2023-08-15 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-08-15
Exact text from the filing
For Against Abstentions Broker Non-Votes 34,131,162 865,249 81,696 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Axogen, Inc. shareholders rejected Amendment and restatement of Axogen, Inc. 2019 Long-Term Incentive Plan to increase shares from 8,000,000 to 10,500,000 at the 2023-08-15 meeting.
- Proposal
- equity plan
- Outcome
- failed
- Meeting
- 2023-08-15
Exact text from the filing
For Against Abstentions Broker Non-Votes 11,294,448 18,612,185 227,801 4,943,673
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.